ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Shares Sold by OLD Mission Capital LLC
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Shares Sold by OLD Mission Capital LLC
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.OLD Mission Capital LLC lessened its holdings in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Rating) by 52.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 15,311 shares of the company's stock after selling 16,895 shares during the period. OLD Mission Capital LLC owned approximately 3.83% of ProShares UltraShort Nasdaq Biotechnology worth $413,000 as of its most recent SEC filing.
根据旧任务资本有限责任公司向美国证券交易委员会(纳斯达克)披露的最新信息，其在第二季度减持了ProShares UltraShort美国证券交易委员会生物科技公司(BIS-GET评级)的股票52.5%。该公司在此期间出售了16,895股后，持有15,311股该公司股票。根据纳斯达克最近提交的申请文件，旧任务资本有限责任公司拥有ProShares UltraShort美国证券交易委员会生物科技公司约3.83%的股份，价值413,000美元。
Separately, UBS Group AG grew its holdings in ProShares UltraShort Nasdaq Biotechnology by 54.7% during the first quarter. UBS Group AG now owns 1,371 shares of the company's stock worth $33,000 after acquiring an additional 485 shares during the period.
另外，瑞银集团(UBS Group AG)第一季度增持了ProShares UltraShort纳斯达克生物科技公司的股份54.7%。瑞银集团(UBS Group AG)在此期间增持了485股，目前持有1,371股该公司股票，价值33,000美元。
ProShares UltraShort Nasdaq Biotechnology Stock Up 2.7 %
ProShares UltraShort纳斯达克生物科技股上涨2.7%
Shares of BIS stock opened at $21.03 on Thursday. The business's fifty day moving average price is $23.46 and its 200 day moving average price is $25.46. ProShares UltraShort Nasdaq Biotechnology has a 1-year low of $18.77 and a 1-year high of $35.64.
周四，国际清算银行股票开盘报21.03美元。该业务的50日移动均线价格为23.46美元，200日移动均线价格为25.46美元。ProShares UltraShort纳斯达克生物科技的一年低点为18.77美元，一年高位为35.64美元。
ProShares UltraShort Nasdaq Biotechnology Profile
ProShares UltraShort纳斯达克生物技术简介
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.
ProShares超纳斯达克生物科技(基金)只寻求一天的投资结果，不寻求较长时期的投资结果。基金寻求扣除费用和费用前的每日投资结果，相当于该指数每日业绩的两倍(200%)。超过一个交易日的基金回报将是这段时间内每一天的回报的复合结果，这很可能与同期纳斯达克生物技术指数(该指数)的回报两倍(200%)不同。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on ProShares UltraShort Nasdaq Biotechnology (BIS)
- Is Triple-Digit Growth Ahead For Digital Ad Platform Trade Desk?
- EV Maker Lucid Falls On Declining Orders, Rivian Up On Guidance
- DoorDash Outperforms Despite Losses – Is It Time To Buy?
- Goodyear Tire & Rubber Stock is Becoming a Mighty Good Bargain
- Analysts Rate DraftKings a Moderate Buy As Growth Slows
- 免费获取StockNews.com关于ProShares UltraShort纳斯达克生物技术的研究报告
- 数字广告平台交易台未来是否会实现三位数的增长？
- 电动汽车制造商Lucid订单下降，Rivian发布指引
- DoorDash在亏损的情况下表现优异-是时候买入了吗？
- 固特异轮胎橡胶库存正在成为一笔划算的交易
- 分析师对DraftKings的评级为温和买入，经济增长放缓
Receive News & Ratings for ProShares UltraShort Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
获得ProShares UltraShort纳斯达克生物科技日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对ProShares UltraShort纳斯达克生物技术和相关公司的最新新闻和分析师评级的每日摘要。
